The University of Notre Dame DU Lac's Notre Dame Research Division, doing business as the Office of Research, received a $471,006.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The 3-year grant, awarded on September 15, 2023, supports a bench-bedside-bidirectional investigation of a new combinatorial immunotherapy strategy to treat platinum-resistant penile cancer. As a leading research university, the University of Notre Dame conducts basic and applied research across a range of scientific disciplines, including engineering, computer science, physics, chemistry, biology, medicine, and social sciences. Through this federal grant, the university's researchers will leverage the institution's specialized laboratories, equipment, and multidisciplinary teams to advance the understanding and treatment of this rare cancer type.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $471.0k | 7/2/23 |